CIK 0001374339
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
ProMIS Neurosciences Inc.
Sign in to watch- Ticker
- PMN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- Operating
- Phone
- +1 416-847-6898
- Business address
- SUITE 200, 1920 YONGE STREET, TORONTO, Ontario, Canada, M4S 3E2
- Former names
- AMORFIX LIFE SCIENCES LTD
- 4 Grant or award Chief Scientific Officer acquired 4,122 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 2,060 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,183 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 6,595 shares (grant or award)
- 4 Grant or award Director acquired 3,050 shares (grant or award)
- 4 Open-market buy 10% owner bought 700,741 shares at $12.13 ($8,499,988)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Principal Accounting Officer bought 30,392 shares at $0.49 ($14,929)
- 4 Option exercise 10% owner acquired 2,093,022 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise 10% owner acquired 2,093,022 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 2 of 6 · 108 filings